Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.20.2
Segment Information
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Segment Information

Note 14—Segment Information

The Company has organized its business into two operating segments based on the product specialties: the vascular segment and the dermatology segment.

In deciding how to allocate resources and assess performance, the Company’s chief operating decision maker regularly evaluates the sales and gross profit of these segments. Amounts included within selling, general and administrative expense and research and development expense are general to the Company and not specific to a particular segment; therefore, these amounts are not evaluated by the Company’s chief operating decision maker on a segmented basis.

The following tables summarize segment performance (in thousands):

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Vascular

 

$

68

 

 

$

226

 

 

$

259

 

 

$

1,121

 

Dermatology

 

 

846

 

 

 

1,682

 

 

 

2,929

 

 

 

4,688

 

Net revenue

 

$

914

 

 

$

1,908

 

 

$

3,188

 

 

$

5,809

 

Vascular

 

$

515

 

 

$

920

 

 

$

1,593

 

 

$

3,510

 

Dermatology

 

 

903

 

 

 

1,505

 

 

 

2,576

 

 

 

3,590

 

Cost of revenue

 

$

1,418

 

 

$

2,425

 

 

$

4,169

 

 

$

7,100

 

Vascular

 

$

(447

)

 

$

(694

)

 

$

(1,334

)

 

$

(2,389

)

Dermatology

 

 

(57

)

 

 

177

 

 

 

353

 

 

 

1,098

 

Gross loss

 

$

(504

)

 

$

(517

)

 

$

(981

)

 

$

(1,291

)

 

 

Generally, all assets are common assets, except for lasers placed with customers, which are a subset of property and equipment. The net book value of the lasers in the vascular segment was $2.0 million and $2.6 million as of September 30, 2020 and December 31, 2019, respectively. The net book value of the lasers in the dermatology segment was $0.7 million and $0.9 million as of September 30, 2020 and December 31, 2019, respectively.

No sales to an individual customer or country other than the United States accounted for more than 10% of revenue for the three and nine months ended September 30, 2020. Sales to one individual customer and country accounted for 13% of revenue in the three months ended September 30, 2019. No sales to an individual customer or country other than the United States accounted for more than 10% of net revenue for the nine months ended September 30, 2019. Net revenue, classified by the major geographic areas in which our customers are located, was as follows (in thousands):

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

United States

 

$

905

 

 

$

1,618

 

 

$

2,972

 

 

$

5,219

 

All other countries

 

 

9

 

 

 

290

 

 

 

216

 

 

 

590

 

Net revenue

 

$

914

 

 

$

1,908

 

 

$

3,188

 

 

$

5,809